Kaplan–Meier analysis revealed that elevated ALDOA levels correlated with a poor prognosis in CRC patients with stage I-III, whereas the prognosis tends to be favorable in patients with advanced CRC. This evidence concerns the gene ALDOA and colorectal carcinoma.